Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of AKT phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same

Use of AKT phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same

US Patent 10288622 · Granted May 14, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Diagnosis of autoimmune disease2024
Methods of treatment of HLA-B27 related inflammatory diseases and compositions r2024
Methods of treatment of HLA-B27 related inflammatory diseases and compositions r2024
Diagnosis of systemic lupus erythematosus using protein, peptide and oligonucleo2024
Peptide compounds and therapeutic uses of same2024
Use of AKT phosphorylation as a biomarker for prognosing neurodegenerative disea2023
Use of AKT phosphorylation as a biomarker for prognosing neurodegenerative disea2023
Use of AKT phosphorylation as a biomarker for prognosing neurodegenerative disea2023
Use of AKT phosphorylation as a biomarker for prognosing neurodegenerative disea2023
Use of AKT phosphorylation as a biomarker for prognosing neurodegenerative disea2023
Diagnosis of systemic lupus erythematosus using oligonucleotides antigens2023
Diagnosis of autoimmune diseases2022